HHS-2026-ACL-AOD-TBSG-0026: TBI State Partnership Program
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Administration for Community Living notices from 2026.
Administration for Community Living offered grants of up to $205,000 (at least $190,000) to state and local governments. It expected to make about 32 awards worth $6.4 million in total. Applications closed on August 13, 2026.
From the official notice on Grants.gov, last changed July 15, 2026. Checked November 7, 2026.
- Award ceiling$205,000
- Award floor$190,000
- Total funding$6.4 million
- Expected awards32
- Cost sharingRequired
- Funding typeGrant
Key dates
| Posted | July 9, 2026 |
|---|---|
| Deadline | August 13, 2026 |
Who can apply
This opportunity was open to state and local governments.
- State governments
State governments, territorial governments, and federally recognized Indian Tribal governments and Native American organizations are the only eligible applicants for funding. The application for a TBI State Partnership Program grant may only come from the agency designated by the Chief Executive Officer of the state as the lead agency for TBI within the state, territory, or Indian tribal government. Only one application from each state, territorial government, federally recognized Indian tribal government or Native American organization may enter the review process to be considered for a TBI State Partnership Program award. Foreign entities are not eligible to compete for, or receive, awards made under this announcement.
Is this a realistic fit?
- Past Traumatic Brain Injury State Demonstration Grant Program awards averaged $339,561; this notice allows up to $205,000 per award.
- Most of the program's money (52% over five years) went to state and local governments.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
N/A
Who has won Traumatic Brain Injury State Demonstration Grant Program grants before
From fiscal 2021 to 2025, Traumatic Brain Injury State Demonstration Grant Program (93.234) awarded $19.0 million across 56 grant awards, an average of $339,561 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Maine Department of Health and Human Services | Maine | 2 | $686,758 |
| Department for Aging and Rehabilitative Services | Virginia | 2 | $686,758 |
| Tennessee Department of Health | Tennessee | 2 | $686,758 |
| University of Alaska Anchorage | Alaska | 2 | $686,758 |
| Health Services Kentucky Cabinet for | Kentucky | 2 | $686,757 |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HHS-2026-ACL-AOD-TBSG-0026 still open?
No. It closed on August 13, 2026.
Who can apply for TBI State Partnership Program?
Administration for Community Living accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.
What is the deadline for TBI State Partnership Program?
Closed August 13, 2026. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $205,000 each. About $6.4 million in total across about 32 awards.
Who has won Traumatic Brain Injury State Demonstration Grant Program grants before?
The largest recipients over five fiscal years were Maine Department of Health and Human Services, Department for Aging and Rehabilitative Services, Tennessee Department of Health. The program made 56 awards worth $19.0 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)